人福医药 (600079.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(人福医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 6,282,091,319.936,493,911,802.836,367,371,531.886,413,022,640.655,728,719,548.116,157,263,293.726,225,735,090.216,082,317,207.535,676,657,282.575,394,222,271.625,184,522,655.83
 营业收入(元) 6,282,091,319.936,493,911,802.836,367,371,531.886,413,022,640.655,728,719,548.116,157,263,293.726,225,735,090.216,082,317,207.535,676,657,282.575,394,222,271.625,184,522,655.83
二、营业总成本(元) 5,517,790,498.835,542,270,566.075,584,162,042.555,700,836,332.825,042,957,633.625,241,349,381.795,431,915,788.855,628,244,756.994,942,215,673.474,617,103,416.144,664,211,013.43
 营业成本(元) 3,347,651,085.483,431,779,659.253,412,875,696.103,484,704,765.403,069,855,273.783,401,421,282.073,335,010,236.103,416,618,596.623,224,199,072.403,108,502,044.692,865,818,298.28
 研发费用(元) 387,424,854.00356,494,287.82349,340,705.03460,772,507.93359,947,208.67355,864,075.96285,358,236.04330,881,907.07213,276,194.99207,650,261.09215,047,329.07
 营业税金及附加(元) 56,669,337.9353,099,686.1851,186,293.9367,147,070.2127,406,656.4147,642,611.0349,550,717.6270,115,340.8049,790,673.3242,001,616.4143,951,500.11
 销售费用(元) 1,096,248,559.931,177,020,073.271,203,802,252.651,036,963,677.58999,169,679.441,089,169,029.131,272,496,388.821,194,052,557.631,065,588,423.50956,419,096.211,058,647,460.41
 管理费用(元) 457,484,446.37449,371,494.73486,502,809.84558,410,819.50487,519,189.01356,408,227.91367,722,651.90508,280,864.31346,320,266.61340,776,084.15356,893,541.67
 财务费用(元) 172,312,215.1274,505,364.8280,454,285.0092,837,492.2099,059,626.31-9,155,844.31121,777,558.37108,295,490.5643,041,042.65-38,245,686.41123,852,883.89
  其中:利息费用(元) 91,221,888.2693,494,366.7285,200,005.5686,482,483.8894,200,626.3879,223,304.9794,235,280.8186,021,363.97124,430,105.30129,707,994.64136,408,541.38
  其中:利息收入(元) 6,549,884.4319,916,130.9113,685,685.2919,276,421.1420,921,527.4911,362,561.407,210,554.993,066,280.1610,922,695.4493,097,868.9136,158,097.18
 资产减值损失(元) -212,262.45-5,023,335.37986,604.69-32,660,658.39468,802.55-29,464,774.63249,327.65-48,350,192.46-36,133,468.16-2,951,686.94-876,581.88
 信用减值损失(元) -18,729,606.08-13,191,225.48-16,877,771.55-93,144,220.14-6,342,767.83-23,398,820.66-24,472,100.757,299,288.24-32,983,215.7992,941,725.5122,838,994.99
三、其他经营收益
 加:公允价值变动收益(元) -1,597,766.11875,430.83-6,536,363.6132,838,112.4515,089,531.73-1,723,668.2290,650,758.9812,792,453.204,625,235.7524,056,737.861,942,127.84
 加:投资收益(元) 51,773,511.5711,838,101.1316,870,550.1610,640,618.098,132,046.9481,228,139.39106,784,674.41-83,160,720.09303,137,620.1038,737,672.90576,842,337.60
  其中:对联营企业和合营企业的投资收益(元) 13,811,745.1814,849,055.6320,275,301.7714,283,620.5110,461,236.4412,607,266.4022,639,587.69-34,174,765.157,342,159.1326,505,644.3822,841,124.63
 资产处置收益(元) -2,580,379.22-1,046,040.24513,191.27-1,740,021.07617,155.88-353,475.62391,415.86-35,138,836.20317,094.612,755,962.78-6,699,028.58
 其他收益(元) 42,575,502.5452,575,761.7444,347,913.7675,820,895.9233,260,189.4352,660,273.0943,961,299.6765,655,896.6834,478,801.7227,351,906.0960,603,096.02
四、营业利润(元) 835,529,821.35997,669,929.37822,513,614.05703,941,034.69736,986,873.19994,861,585.281,011,384,677.18373,170,339.911,007,883,677.33960,011,173.681,174,962,588.39
 加:营业外收入(元) 5,215,709.97638,263.70627,700.466,874,582.04-538,751.91-301,921.762,250,674.52-780,057.544,006,876.60505,647.731,711,570.48
 减:营业外支出(元) 27,230,676.9932,364,892.2913,616,262.6734,263,221.7921,620,619.755,317,574.1310,428,505.5930,244,440.4046,012,500.058,854,569.0810,307,441.90
五、利润总额(元) 813,514,854.33965,943,300.78809,525,051.84676,552,394.94714,827,501.53989,242,089.391,003,206,846.11342,145,841.97965,878,053.88951,662,252.331,166,366,716.97
 减:所得税费用(元) 161,764,428.46158,501,743.80161,336,256.36144,437,299.62122,364,268.52159,668,132.53142,093,319.60-45,419,181.24115,191,455.81157,211,697.56127,766,574.64
六、净利润(元) 651,750,425.87807,441,556.98648,188,795.48532,115,095.32592,463,233.01829,573,956.86861,113,526.51387,565,023.21850,686,598.07794,450,554.771,038,600,142.33
(一)按经营持续性分类
  持续经营净利润(元) 651,750,425.87807,441,556.98648,188,795.48532,115,095.32592,463,233.01829,573,956.86861,113,526.51387,565,023.21850,686,598.07794,450,554.771,038,600,142.33
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 478,599,417.99624,702,928.78486,392,045.37365,773,414.53444,898,742.66658,495,566.96665,316,964.81259,336,419.78721,838,254.57588,594,517.13914,339,393.95
  少数股东损益(元) 173,151,007.88182,738,628.20161,796,750.11166,341,680.79147,564,490.35171,078,389.90195,796,561.70128,228,603.43128,848,343.50205,856,037.64124,260,748.38
 扣除非经常性损益后的净利润(元) 432,119,904.58624,666,118.58464,342,153.96319,138,179.36431,944,497.88562,603,442.09508,455,478.82282,700,161.70423,694,890.30531,288,726.02310,236,528.61
七、每股收益
 一、基本每股收益(元) 0.300.380.300.230.270.410.410.160.450.360.57
 二、稀释每股收益(元) 0.290.380.300.220.280.400.410.160.450.370.56
八、其他综合收益(元) 255,369,129.37-98,538,046.80-35,025,830.50-55,848,672.1926,160,726.8060,475,021.271,583,453.59-56,542,306.85155,668,278.3574,225,017.46-17,579,967.66
 归属于母公司股东的其他综合收益(元) 256,445,893.97-93,953,735.89-31,008,824.54-51,620,416.3529,530,755.0457,060,067.951,349,275.18-65,064,094.50155,296,657.5788,623,100.08-17,168,279.44
 归属于少数股东的其他综合收益(元) -1,076,764.60-4,584,310.91-4,017,005.96-4,228,255.84-3,370,028.243,414,953.32234,178.418,521,787.65371,620.78-14,398,082.62-411,688.22
九、综合收益总额(元) 907,119,555.24708,903,510.18613,162,964.98476,266,423.13618,623,959.81890,048,978.13862,696,980.10331,022,716.361,006,354,876.42868,675,572.231,021,020,174.67
 归属于母公司所有者的综合收益总额(元) 735,045,311.96530,749,192.89455,383,220.83314,152,998.18474,429,497.70715,555,634.91666,666,239.99194,272,325.28877,134,912.14677,217,617.21897,171,114.51
 归属于少数股东的综合收益总额(元) 172,074,243.28178,154,317.29157,779,744.15162,113,424.95144,194,462.11174,493,343.22196,030,740.11136,750,391.08129,219,964.28191,457,955.02123,849,060.16
公告日期 2024-10-302024-07-272024-04-302024-03-292023-10-272023-08-252023-04-282023-03-242022-10-282022-08-262022-04-28
审计意见(境内) 标准无保留意见标准无保留意见

前瞻产业研究院